Advertisement

Topics

ImmunoMolecular Therapeutics ImmunoMolecular Therapeutics Company Profile

06:56 EDT 22nd April 2018 | BioPortfolio


News Articles [5067 Associated News Articles listed on BioPortfolio]

BRIEF—New company targets immunotherapies for genetically-defined type 1 diabetes and other autoimmune diseases

ImmunoMolecular Therapeutics (IM Therapeutics), a company developing personalized small molecule therapies…

IM Therapeutics Spins Out of University of Colorado to Focus on Type 1 Diabetes

ImmunoMolecular Therapeputics officially launched yesterday.

ImmunoMolecular Therapeutics Announces Two Issued Patents for Small Molecule Therapies in Type 1 Diabetes and Celiac Disease

ImmunoMolecular Therapeutics (IM Therapeutics), a company developing personalized small molecule therapies for the treatment of genetically defined autoimmune diseases, today anno...

CORRECTING and REPLACING ImmunoMolecular Therapeutics To Present at the 10th Annual Biotech Showcase

-- Update on HLA-MHC Class II target platform for autoimmune diseases -– First paragraph, second sentence of release should read: The presentation is scheduled for Tu...

Global Veterinary Therapeutics Market to Mark CAGR of 6.0% Over Next 10 Years - MarketResearch.biz

MarketResearch.biz announces publication of its recently generated research report titled, "GlobalVeterinary Therapeutics MarketBy Type (Therapeutics Drugs, Therapeutics Vaccines, Feed Additives The...

ImmunoMolecular Therapeutics To Present at the 10th Annual Biotech Showcase

-- Update on HLA-MHC Class II target platform for autoimmune diseases -– ImmunoMolecular Therapeutics (IM Therapeutics), a company developing personalized small molec...

What You Need to Know About Indalo Therapeutics

Indalo Therapeutics is based in St. Louis and was formed in October 2016 from the merger of Antegrin Therapeutics and Cascadia Therapeutics.

ImmunoMolecular Therapeutics Launches to Advance Innovative Immuno therapi es for Genetically Defined Type 1 Diabetes and Other Autoimmune Diseases

ImmunoMolecular Therapeutics (IM Therapeutics), a company developing personalized small molecule therapies for the treatment of genetically defined autoimmune diseases, today made its deb...

PubMed Articles [1365 Associated PubMed Articles listed on BioPortfolio]

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

Eyes on New Product Development: Preclinical Research.

Eyes on New Product Development: Preclinical Research.

Introduction to Volume 1 of JOPT Special Issue.

Clinical Trials [142 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1608 Associated Companies listed on BioPortfolio]

ImmunoMolecular Therapeutics ImmunoMolecular Therapeutics

ImmunoMolecular Therapeutics

IM Therapeutics is developing personalized immuno-therapeutic drugs for autoimmune diseases based on the genetic risk attributed by human leukocyte antigen genes. The lead candida...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "ImmunoMolecular Therapeutics ImmunoMolecular Therapeutics" on BioPortfolio

We have published hundreds of ImmunoMolecular Therapeutics ImmunoMolecular Therapeutics news stories on BioPortfolio along with dozens of ImmunoMolecular Therapeutics ImmunoMolecular Therapeutics Clinical Trials and PubMed Articles about ImmunoMolecular Therapeutics ImmunoMolecular Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ImmunoMolecular Therapeutics ImmunoMolecular Therapeutics Companies in our database. You can also find out about relevant ImmunoMolecular Therapeutics ImmunoMolecular Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record